ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Digital Pathology Platform Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-31D17211
Home | Market Reports | Health
Global Digital Pathology Platform Market Research Report 2024
BUY CHAPTERS

Global Digital Pathology Platform Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-31D17211
Report
October 2025
Pages:174
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Leica Biosystems
Olympus
Philips
Roche
3DHISTECH
Hamamatsu Photonics
Zeiss
OptraSCAN
Media Cyber​​netics
Visiopharm
Sectra
Digital Slide Archive
Aiforia
PathAI
Pathomation
Proscia, Inc.
Indica Labs
Gestalt Gmbh
Xybion
NovoPath, Inc.
Glencoe Software
Orbit Image Analysis
Augmentiqs

Digital Pathology Platform Market

The global Digital Pathology Platform market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
A digital pathology platform is an integrated system designed to digitize, manage, analyze, and share pathology information through high-resolution digital images of tissue samples. This platform includes components such as slide scanners that convert glass slides into digital images, image management software for storing and organizing these images, and analysis tools that often incorporate artificial intelligence (AI) to assist in diagnosing and quantifying disease markers. Additionally, digital pathology platforms facilitate remote consultations and collaborative review by allowing pathologists to share images and annotations with colleagues worldwide. By streamlining workflows, enhancing diagnostic accuracy, and improving data accessibility, digital pathology platforms play a crucial role in modernizing pathology practices and advancing medical research.
From a downstream perspective, Pharmaceutical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Digital Pathology Platform leading manufacturers including Leica Biosystems, Olympus, Philips, Roche, 3DHISTECH, Hamamatsu Photonics, ZEISS, OptraScan, Media Cyber​​netics, Visiopharm, etc., dominate supply; the top five capture approximately % of global revenue, with Leica Biosystems leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Digital Pathology Platform market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Digital Pathology Platform Market Report

Report Metric Details
Report Name Digital Pathology Platform Market
Segment by Type
  • Open-Source Platforms
  • Closed-Source Platforms
Segment by Application
  • Pharmaceutical
  • Clinical Use
  • Research
  • Education
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Leica Biosystems, Olympus, Philips, Roche, 3DHISTECH, Hamamatsu Photonics, ZEISS, OptraScan, Media Cyber​​netics, Visiopharm, Sectra, Digital Slide Archive, Aiforia, PathAI, Pathomation, Proscia, Indica Labs, Gestalt, Xybion, NovoPath, Glencoe Software, Orbit Image Analysis, Augmentiqs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Digital Pathology Platform study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Digital Pathology Platform Market report?

Ans: The main players in the Digital Pathology Platform Market are Leica Biosystems, Olympus, Philips, Roche, 3DHISTECH, Hamamatsu Photonics, ZEISS, OptraScan, Media Cyber​​netics, Visiopharm, Sectra, Digital Slide Archive, Aiforia, PathAI, Pathomation, Proscia, Indica Labs, Gestalt, Xybion, NovoPath, Glencoe Software, Orbit Image Analysis, Augmentiqs

What are the Application segmentation covered in the Digital Pathology Platform Market report?

Ans: The Applications covered in the Digital Pathology Platform Market report are Pharmaceutical, Clinical Use, Research, Education

What are the Type segmentation covered in the Digital Pathology Platform Market report?

Ans: The Types covered in the Digital Pathology Platform Market report are Open-Source Platforms, Closed-Source Platforms

Recommended Reports

Digital Pathology Platforms

Pathology Slide Scanners

Pathology Imaging Analysis

1 Study Coverage
1.1 Introduction to Digital Pathology Platform: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Digital Pathology Platform Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Open-Source Platforms
1.2.3 Closed-Source Platforms
1.3 Market Segmentation by Application
1.3.1 Global Digital Pathology Platform Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Clinical Use
1.3.4 Research
1.3.5 Education
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Digital Pathology Platform Revenue Estimates and Forecasts 2020-2031
2.2 Global Digital Pathology Platform Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Digital Pathology Platform Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Digital Pathology Platform Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Open-Source Platforms Market Size by Players
3.3.2 Closed-Source Platforms Market Size by Players
3.4 Global Digital Pathology Platform Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Digital Pathology Platform Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Digital Pathology Platform Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Digital Pathology Platform Market Size by Type (2020-2031)
6.4 North America Digital Pathology Platform Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Digital Pathology Platform Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Digital Pathology Platform Market Size by Type (2020-2031)
7.4 Europe Digital Pathology Platform Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Digital Pathology Platform Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Digital Pathology Platform Market Size by Type (2020-2031)
8.4 Asia-Pacific Digital Pathology Platform Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Digital Pathology Platform Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Digital Pathology Platform Market Size by Type (2020-2031)
9.4 Central and South America Digital Pathology Platform Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Digital Pathology Platform Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Digital Pathology Platform Market Size by Type (2020-2031)
10.4 Middle East and Africa Digital Pathology Platform Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Digital Pathology Platform Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Leica Biosystems
11.1.1 Leica Biosystems Corporation Information
11.1.2 Leica Biosystems Business Overview
11.1.3 Leica Biosystems Digital Pathology Platform Product Features and Attributes
11.1.4 Leica Biosystems Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.1.5 Leica Biosystems Digital Pathology Platform Revenue by Product in 2024
11.1.6 Leica Biosystems Digital Pathology Platform Revenue by Application in 2024
11.1.7 Leica Biosystems Digital Pathology Platform Revenue by Geographic Area in 2024
11.1.8 Leica Biosystems Digital Pathology Platform SWOT Analysis
11.1.9 Leica Biosystems Recent Developments
11.2 Olympus
11.2.1 Olympus Corporation Information
11.2.2 Olympus Business Overview
11.2.3 Olympus Digital Pathology Platform Product Features and Attributes
11.2.4 Olympus Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.2.5 Olympus Digital Pathology Platform Revenue by Product in 2024
11.2.6 Olympus Digital Pathology Platform Revenue by Application in 2024
11.2.7 Olympus Digital Pathology Platform Revenue by Geographic Area in 2024
11.2.8 Olympus Digital Pathology Platform SWOT Analysis
11.2.9 Olympus Recent Developments
11.3 Philips
11.3.1 Philips Corporation Information
11.3.2 Philips Business Overview
11.3.3 Philips Digital Pathology Platform Product Features and Attributes
11.3.4 Philips Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.3.5 Philips Digital Pathology Platform Revenue by Product in 2024
11.3.6 Philips Digital Pathology Platform Revenue by Application in 2024
11.3.7 Philips Digital Pathology Platform Revenue by Geographic Area in 2024
11.3.8 Philips Digital Pathology Platform SWOT Analysis
11.3.9 Philips Recent Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Business Overview
11.4.3 Roche Digital Pathology Platform Product Features and Attributes
11.4.4 Roche Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.4.5 Roche Digital Pathology Platform Revenue by Product in 2024
11.4.6 Roche Digital Pathology Platform Revenue by Application in 2024
11.4.7 Roche Digital Pathology Platform Revenue by Geographic Area in 2024
11.4.8 Roche Digital Pathology Platform SWOT Analysis
11.4.9 Roche Recent Developments
11.5 3DHISTECH
11.5.1 3DHISTECH Corporation Information
11.5.2 3DHISTECH Business Overview
11.5.3 3DHISTECH Digital Pathology Platform Product Features and Attributes
11.5.4 3DHISTECH Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.5.5 3DHISTECH Digital Pathology Platform Revenue by Product in 2024
11.5.6 3DHISTECH Digital Pathology Platform Revenue by Application in 2024
11.5.7 3DHISTECH Digital Pathology Platform Revenue by Geographic Area in 2024
11.5.8 3DHISTECH Digital Pathology Platform SWOT Analysis
11.5.9 3DHISTECH Recent Developments
11.6 Hamamatsu Photonics
11.6.1 Hamamatsu Photonics Corporation Information
11.6.2 Hamamatsu Photonics Business Overview
11.6.3 Hamamatsu Photonics Digital Pathology Platform Product Features and Attributes
11.6.4 Hamamatsu Photonics Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.6.5 Hamamatsu Photonics Recent Developments
11.7 ZEISS
11.7.1 ZEISS Corporation Information
11.7.2 ZEISS Business Overview
11.7.3 ZEISS Digital Pathology Platform Product Features and Attributes
11.7.4 ZEISS Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.7.5 ZEISS Recent Developments
11.8 OptraScan
11.8.1 OptraScan Corporation Information
11.8.2 OptraScan Business Overview
11.8.3 OptraScan Digital Pathology Platform Product Features and Attributes
11.8.4 OptraScan Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.8.5 OptraScan Recent Developments
11.9 Media Cyber​​netics
11.9.1 Media Cyber​​netics Corporation Information
11.9.2 Media Cyber​​netics Business Overview
11.9.3 Media Cyber​​netics Digital Pathology Platform Product Features and Attributes
11.9.4 Media Cyber​​netics Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.9.5 Media Cyber​​netics Recent Developments
11.10 Visiopharm
11.10.1 Visiopharm Corporation Information
11.10.2 Visiopharm Business Overview
11.10.3 Visiopharm Digital Pathology Platform Product Features and Attributes
11.10.4 Visiopharm Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Sectra
11.11.1 Sectra Corporation Information
11.11.2 Sectra Business Overview
11.11.3 Sectra Digital Pathology Platform Product Features and Attributes
11.11.4 Sectra Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.11.5 Sectra Recent Developments
11.12 Digital Slide Archive
11.12.1 Digital Slide Archive Corporation Information
11.12.2 Digital Slide Archive Business Overview
11.12.3 Digital Slide Archive Digital Pathology Platform Product Features and Attributes
11.12.4 Digital Slide Archive Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.12.5 Digital Slide Archive Recent Developments
11.13 Aiforia
11.13.1 Aiforia Corporation Information
11.13.2 Aiforia Business Overview
11.13.3 Aiforia Digital Pathology Platform Product Features and Attributes
11.13.4 Aiforia Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.13.5 Aiforia Recent Developments
11.14 PathAI
11.14.1 PathAI Corporation Information
11.14.2 PathAI Business Overview
11.14.3 PathAI Digital Pathology Platform Product Features and Attributes
11.14.4 PathAI Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.14.5 PathAI Recent Developments
11.15 Pathomation
11.15.1 Pathomation Corporation Information
11.15.2 Pathomation Business Overview
11.15.3 Pathomation Digital Pathology Platform Product Features and Attributes
11.15.4 Pathomation Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.15.5 Pathomation Recent Developments
11.16 Proscia
11.16.1 Proscia Corporation Information
11.16.2 Proscia Business Overview
11.16.3 Proscia Digital Pathology Platform Product Features and Attributes
11.16.4 Proscia Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.16.5 Proscia Recent Developments
11.17 Indica Labs
11.17.1 Indica Labs Corporation Information
11.17.2 Indica Labs Business Overview
11.17.3 Indica Labs Digital Pathology Platform Product Features and Attributes
11.17.4 Indica Labs Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.17.5 Indica Labs Recent Developments
11.18 Gestalt
11.18.1 Gestalt Corporation Information
11.18.2 Gestalt Business Overview
11.18.3 Gestalt Digital Pathology Platform Product Features and Attributes
11.18.4 Gestalt Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.18.5 Gestalt Recent Developments
11.19 Xybion
11.19.1 Xybion Corporation Information
11.19.2 Xybion Business Overview
11.19.3 Xybion Digital Pathology Platform Product Features and Attributes
11.19.4 Xybion Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.19.5 Xybion Recent Developments
11.20 NovoPath
11.20.1 NovoPath Corporation Information
11.20.2 NovoPath Business Overview
11.20.3 NovoPath Digital Pathology Platform Product Features and Attributes
11.20.4 NovoPath Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.20.5 NovoPath Recent Developments
11.21 Glencoe Software
11.21.1 Glencoe Software Corporation Information
11.21.2 Glencoe Software Business Overview
11.21.3 Glencoe Software Digital Pathology Platform Product Features and Attributes
11.21.4 Glencoe Software Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.21.5 Glencoe Software Recent Developments
11.22 Orbit Image Analysis
11.22.1 Orbit Image Analysis Corporation Information
11.22.2 Orbit Image Analysis Business Overview
11.22.3 Orbit Image Analysis Digital Pathology Platform Product Features and Attributes
11.22.4 Orbit Image Analysis Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.22.5 Orbit Image Analysis Recent Developments
11.23 Augmentiqs
11.23.1 Augmentiqs Corporation Information
11.23.2 Augmentiqs Business Overview
11.23.3 Augmentiqs Digital Pathology Platform Product Features and Attributes
11.23.4 Augmentiqs Digital Pathology Platform Revenue and Gross Margin (2020-2025)
11.23.5 Augmentiqs Recent Developments
12 Digital Pathology PlatformIndustry Chain Analysis
12.1 Digital Pathology Platform Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Digital Pathology Platform Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Digital Pathology Platform Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Leica Biosystems
Olympus
Philips
Roche
3DHISTECH
Hamamatsu Photonics
Zeiss
OptraSCAN
Media Cyber​​netics
Visiopharm
Sectra
Digital Slide Archive
Aiforia
PathAI
Pathomation
Proscia, Inc.
Indica Labs
Gestalt Gmbh
Xybion
NovoPath, Inc.
Glencoe Software
Orbit Image Analysis
Augmentiqs
List of Tables
 Table 1. Global Digital Pathology Platform Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Digital Pathology Platform Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Digital Pathology Platform Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Digital Pathology Platform Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Digital Pathology Platform Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Digital Pathology Platform Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Digital Pathology Platform Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Digital Pathology Platform by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Pathology Platform as of 2024)
 Table 11. Global Digital Pathology Platform Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Digital Pathology Platform Companies Headquarters
 Table 13. Global Digital Pathology Platform Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Digital Pathology Platform Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Digital Pathology Platform Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Digital Pathology Platform Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Digital Pathology Platform Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Digital Pathology Platform High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Digital Pathology Platform Growth Accelerators and Market Barriers
 Table 25. North America Digital Pathology Platform Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Digital Pathology Platform Growth Accelerators and Market Barriers
 Table 27. Europe Digital Pathology Platform Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Digital Pathology Platform Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Digital Pathology Platform Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Digital Pathology Platform Investment Opportunities and Key Challenges
 Table 31. Central and South America Digital Pathology Platform Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Digital Pathology Platform Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Digital Pathology Platform Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Leica Biosystems Corporation Information
 Table 35. Leica Biosystems Description and Major Businesses
 Table 36. Leica Biosystems Product Features and Attributes
 Table 37. Leica Biosystems Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Leica Biosystems Revenue Proportion by Product in 2024
 Table 39. Leica Biosystems Revenue Proportion by Application in 2024
 Table 40. Leica Biosystems Revenue Proportion by Geographic Area in 2024
 Table 41. Leica Biosystems Digital Pathology Platform SWOT Analysis
 Table 42. Leica Biosystems Recent Developments
 Table 43. Olympus Corporation Information
 Table 44. Olympus Description and Major Businesses
 Table 45. Olympus Product Features and Attributes
 Table 46. Olympus Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Olympus Revenue Proportion by Product in 2024
 Table 48. Olympus Revenue Proportion by Application in 2024
 Table 49. Olympus Revenue Proportion by Geographic Area in 2024
 Table 50. Olympus Digital Pathology Platform SWOT Analysis
 Table 51. Olympus Recent Developments
 Table 52. Philips Corporation Information
 Table 53. Philips Description and Major Businesses
 Table 54. Philips Product Features and Attributes
 Table 55. Philips Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Philips Revenue Proportion by Product in 2024
 Table 57. Philips Revenue Proportion by Application in 2024
 Table 58. Philips Revenue Proportion by Geographic Area in 2024
 Table 59. Philips Digital Pathology Platform SWOT Analysis
 Table 60. Philips Recent Developments
 Table 61. Roche Corporation Information
 Table 62. Roche Description and Major Businesses
 Table 63. Roche Product Features and Attributes
 Table 64. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Roche Revenue Proportion by Product in 2024
 Table 66. Roche Revenue Proportion by Application in 2024
 Table 67. Roche Revenue Proportion by Geographic Area in 2024
 Table 68. Roche Digital Pathology Platform SWOT Analysis
 Table 69. Roche Recent Developments
 Table 70. 3DHISTECH Corporation Information
 Table 71. 3DHISTECH Description and Major Businesses
 Table 72. 3DHISTECH Product Features and Attributes
 Table 73. 3DHISTECH Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. 3DHISTECH Revenue Proportion by Product in 2024
 Table 75. 3DHISTECH Revenue Proportion by Application in 2024
 Table 76. 3DHISTECH Revenue Proportion by Geographic Area in 2024
 Table 77. 3DHISTECH Digital Pathology Platform SWOT Analysis
 Table 78. 3DHISTECH Recent Developments
 Table 79. Hamamatsu Photonics Corporation Information
 Table 80. Hamamatsu Photonics Description and Major Businesses
 Table 81. Hamamatsu Photonics Product Features and Attributes
 Table 82. Hamamatsu Photonics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Hamamatsu Photonics Recent Developments
 Table 84. ZEISS Corporation Information
 Table 85. ZEISS Description and Major Businesses
 Table 86. ZEISS Product Features and Attributes
 Table 87. ZEISS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. ZEISS Recent Developments
 Table 89. OptraScan Corporation Information
 Table 90. OptraScan Description and Major Businesses
 Table 91. OptraScan Product Features and Attributes
 Table 92. OptraScan Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. OptraScan Recent Developments
 Table 94. Media Cyber​​netics Corporation Information
 Table 95. Media Cyber​​netics Description and Major Businesses
 Table 96. Media Cyber​​netics Product Features and Attributes
 Table 97. Media Cyber​​netics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Media Cyber​​netics Recent Developments
 Table 99. Visiopharm Corporation Information
 Table 100. Visiopharm Description and Major Businesses
 Table 101. Visiopharm Product Features and Attributes
 Table 102. Visiopharm Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Visiopharm Recent Developments
 Table 104. Sectra Corporation Information
 Table 105. Sectra Description and Major Businesses
 Table 106. Sectra Product Features and Attributes
 Table 107. Sectra Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Sectra Recent Developments
 Table 109. Digital Slide Archive Corporation Information
 Table 110. Digital Slide Archive Description and Major Businesses
 Table 111. Digital Slide Archive Product Features and Attributes
 Table 112. Digital Slide Archive Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Digital Slide Archive Recent Developments
 Table 114. Aiforia Corporation Information
 Table 115. Aiforia Description and Major Businesses
 Table 116. Aiforia Product Features and Attributes
 Table 117. Aiforia Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Aiforia Recent Developments
 Table 119. PathAI Corporation Information
 Table 120. PathAI Description and Major Businesses
 Table 121. PathAI Product Features and Attributes
 Table 122. PathAI Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. PathAI Recent Developments
 Table 124. Pathomation Corporation Information
 Table 125. Pathomation Description and Major Businesses
 Table 126. Pathomation Product Features and Attributes
 Table 127. Pathomation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Pathomation Recent Developments
 Table 129. Proscia Corporation Information
 Table 130. Proscia Description and Major Businesses
 Table 131. Proscia Product Features and Attributes
 Table 132. Proscia Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Proscia Recent Developments
 Table 134. Indica Labs Corporation Information
 Table 135. Indica Labs Description and Major Businesses
 Table 136. Indica Labs Product Features and Attributes
 Table 137. Indica Labs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Indica Labs Recent Developments
 Table 139. Gestalt Corporation Information
 Table 140. Gestalt Description and Major Businesses
 Table 141. Gestalt Product Features and Attributes
 Table 142. Gestalt Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Gestalt Recent Developments
 Table 144. Xybion Corporation Information
 Table 145. Xybion Description and Major Businesses
 Table 146. Xybion Product Features and Attributes
 Table 147. Xybion Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. Xybion Recent Developments
 Table 149. NovoPath Corporation Information
 Table 150. NovoPath Description and Major Businesses
 Table 151. NovoPath Product Features and Attributes
 Table 152. NovoPath Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. NovoPath Recent Developments
 Table 154. Glencoe Software Corporation Information
 Table 155. Glencoe Software Description and Major Businesses
 Table 156. Glencoe Software Product Features and Attributes
 Table 157. Glencoe Software Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 158. Glencoe Software Recent Developments
 Table 159. Orbit Image Analysis Corporation Information
 Table 160. Orbit Image Analysis Description and Major Businesses
 Table 161. Orbit Image Analysis Product Features and Attributes
 Table 162. Orbit Image Analysis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 163. Orbit Image Analysis Recent Developments
 Table 164. Augmentiqs Corporation Information
 Table 165. Augmentiqs Description and Major Businesses
 Table 166. Augmentiqs Product Features and Attributes
 Table 167. Augmentiqs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 168. Augmentiqs Recent Developments
 Table 169. Raw Materials Key Suppliers
 Table 170. Distributors List
 Table 171. Market Trends and Market Evolution
 Table 172. Market Drivers and Opportunities
 Table 173. Market Challenges, Risks, and Restraints
 Table 174. Research Programs/Design for This Report
 Table 175. Key Data Information from Secondary Sources
 Table 176. Key Data Information from Primary Sources


List of Figures
 Figure 1. Digital Pathology Platform Product Picture
 Figure 2. Global Digital Pathology Platform Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Open-Source Platforms Product Picture
 Figure 4. Closed-Source Platforms Product Picture
 Figure 5. Global Digital Pathology Platform Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Pharmaceutical
 Figure 7. Clinical Use
 Figure 8. Research
 Figure 9. Education
 Figure 10. Digital Pathology Platform Report Years Considered
 Figure 11. Global Digital Pathology Platform Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Digital Pathology Platform Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Digital Pathology Platform Revenue Market Share by Region (2020-2031)
 Figure 15. Global Digital Pathology Platform Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Open-Source Platforms Revenue Market Share by Player in 2024
 Figure 18. Closed-Source Platforms Revenue Market Share by Player in 2024
 Figure 19. Global Digital Pathology Platform Revenue Market Share by Type (2020-2031)
 Figure 20. Global Digital Pathology Platform Revenue Market Share by Application (2020-2031)
 Figure 21. North America Digital Pathology Platform Revenue YoY (2020-2031) & (US$ Million)
 Figure 22. North America Top 5 Players Digital Pathology Platform Revenue (US$ Million) in 2024
 Figure 23. North America Digital Pathology Platform Revenue (US$ Million) by Type (2020 - 2031)
 Figure 24. North America Digital Pathology Platform Revenue (US$ Million) by Application (2020-2031)
 Figure 25. US Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 26. Canada Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 27. Mexico Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 28. Europe Digital Pathology Platform Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Europe Top 5 Players Digital Pathology Platform Revenue (US$ Million) in 2024
 Figure 30. Europe Digital Pathology Platform Revenue (US$ Million) by Type (2020-2031)
 Figure 31. Europe Digital Pathology Platform Revenue (US$ Million) by Application (2020-2031)
 Figure 32. Germany Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 33. France Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 34. U.K. Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 35. Italy Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 36. Russia Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Digital Pathology Platform Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Top 8 Players Digital Pathology Platform Revenue (US$ Million) in 2024
 Figure 39. Asia-Pacific Digital Pathology Platform Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Asia-Pacific Digital Pathology Platform Revenue (US$ Million) by Application (2020-2031)
 Figure 41. Indonesia Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 42. Japan Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 43. South Korea Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 44. Australia Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 45. India Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 46. Indonesia Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 47. Vietnam Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 48. Malaysia Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 49. Philippines Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 50. Singapore Digital Pathology Platform Revenue (2020-2031) & (US$ Million)
 Figure 51. Central and South America Digital Pathology Platform Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Central and South America Top 5 Players Digital Pathology Platform Revenue (US$ Million) in 2024
 Figure 53. Central and South America Digital Pathology Platform Revenue (US$ Million) by Type (2020-2031)
 Figure 54. Central and South America Digital Pathology Platform Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Brazil Digital Pathology Platform Revenue (2020-2025) & (US$ Million)
 Figure 56. Argentina Digital Pathology Platform Revenue (2020-2025) & (US$ Million)
 Figure 57. Middle East and Africa Digital Pathology Platform Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Middle East and Africa Top 5 Players Digital Pathology Platform Revenue (US$ Million) in 2024
 Figure 59. South America Digital Pathology Platform Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Middle East and Africa Digital Pathology Platform Revenue (US$ Million) by Application (2020-2031)
 Figure 61. GCC Countries Digital Pathology Platform Revenue (2020-2025) & (US$ Million)
 Figure 62. Israel Digital Pathology Platform Revenue (2020-2025) & (US$ Million)
 Figure 63. Egypt Digital Pathology Platform Revenue (2020-2025) & (US$ Million)
 Figure 64. South Africa Digital Pathology Platform Revenue (2020-2025) & (US$ Million)
 Figure 65. Digital Pathology Platform Industry Chain Mapping
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Digital Pathology Software and Platform Market Research Report 2024
Global Software Tools And Platforms For Digital Pathology Market Research Report 2024
Global Digital Pathology Software Market Research Report 2024
Global Digital Pathology Image Analysis Platform Market Research Report 2024
Digital Pathology Systems Market
Digital Pathology Remote Diagnosis Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digital Pathology Solution Market Research Report 2024
Global Digital Pathology Slide Scanning System Market Research Report 2024
Global Clinical Digital Pathology Market Research Report 2025
Digital Pathology Analytic Market
Global Digital Pathology AI Assisted Diagnostic System Market Research Report 2025
Global Automatic Digital Pathology Slide Scanning System Market Research Report 2025
Global Digital Pathology Slide Scanner Market Research Report 2024
Global Comprehensive Digital Pathology Scanner Market Research Report 2024
Global Advanced Digital Pathology Solutions Market Research Report 2024
Global Whole Slide Imaging in Pathology Market Research Report 2024
Global Digital Pathology Whole slide Scanners Market Research Report 2024
Global Digital Pathology Scanner Market Research Report 2025
Global Digital Pathology Image Analysis Software for Clinical Market Research Report 2024
Global Real time Digital Pathology Slide Scanner Market Research Report 2024

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions